MMPs in learning and memory and neuropsychiatric disorders
- PMID: 31172215
- PMCID: PMC6647627
- DOI: 10.1007/s00018-019-03180-8
MMPs in learning and memory and neuropsychiatric disorders
Abstract
Matrix metalloproteinases (MMPs) are a group of over twenty proteases, operating chiefly extracellularly to cleave components of the extracellular matrix, cell adhesion molecules as well as cytokines and growth factors. By virtue of their expression and activity patterns in animal models and clinical investigations, as well as functional studies with gene knockouts and enzyme inhibitors, MMPs have been demonstrated to play a paramount role in many physiological and pathological processes in the brain. In particular, they have been shown to influence learning and memory processes, as well as major neuropsychiatric disorders such as schizophrenia, various kinds of addiction, epilepsy, fragile X syndrome, and depression. A possible link connecting all those conditions is either physiological or aberrant synaptic plasticity where some MMPs, e.g., MMP-9, have been demonstrated to contribute to the structural and functional reorganization of excitatory synapses that are located on dendritic spines. Another common theme linking the aforementioned pathological conditions is neuroinflammation and MMPs have also been shown to be important mediators of immune responses.
Keywords: Addiction; Autism; Behavioral training; Epilepsy; Schizophrenia.
Similar articles
-
From c-Fos to MMP-9: In control of synaptic plasticity to produce healthy and diseased mind, a personal view.Postepy Biochem. 2018 Oct 15;64(2):101-109. doi: 10.18388/pb.2018_119. Postepy Biochem. 2018. PMID: 30656892 English.
-
Extracellular Metalloproteinases in the Plasticity of Excitatory and Inhibitory Synapses.Cells. 2021 Aug 11;10(8):2055. doi: 10.3390/cells10082055. Cells. 2021. PMID: 34440823 Free PMC article. Review.
-
Upregulated expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in BALB/c mouse brain challenged with Japanese encephalitis virus.Neuroimmunomodulation. 2012;19(4):241-54. doi: 10.1159/000335182. Epub 2012 Mar 21. Neuroimmunomodulation. 2012. PMID: 22441541
-
Matrix metalloprotease activity shapes the magnitude of EPSPs and spike plasticity within the hippocampal CA3 network.Hippocampus. 2014 Feb;24(2):135-53. doi: 10.1002/hipo.22205. Epub 2013 Oct 15. Hippocampus. 2014. PMID: 24115249
-
MMP-9 in translation: from molecule to brain physiology, pathology, and therapy.J Neurochem. 2016 Oct;139 Suppl 2:91-114. doi: 10.1111/jnc.13415. Epub 2016 Mar 21. J Neurochem. 2016. PMID: 26525923 Review.
Cited by
-
Matrix metalloproteinase 9 (MMP-9) activity, hippocampal extracellular free water, and cognitive deficits are associated with each other in early phase psychosis.Neuropsychopharmacology. 2024 Mar 2. doi: 10.1038/s41386-024-01814-5. Online ahead of print. Neuropsychopharmacology. 2024. PMID: 38431757
-
Epidermal Growth Factor Suppresses the Development of GABAergic Neurons Via the Modulation of Perineuronal Net Formation in the Neocortex of Developing Rodent Brains.Neurochem Res. 2024 Feb 14. doi: 10.1007/s11064-024-04122-y. Online ahead of print. Neurochem Res. 2024. PMID: 38353896
-
The impact of doxycycline on human contextual fear memory.Psychopharmacology (Berl). 2024 Feb 9. doi: 10.1007/s00213-024-06540-w. Online ahead of print. Psychopharmacology (Berl). 2024. PMID: 38334789
-
System biology approaches to identify hub genes linked with ECM organization and inflammatory signaling pathways in schizophrenia pathogenesis.Heliyon. 2024 Jan 26;10(3):e25191. doi: 10.1016/j.heliyon.2024.e25191. eCollection 2024 Feb 15. Heliyon. 2024. PMID: 38322840 Free PMC article.
-
Identification of m6A-Related Biomarkers in Systemic Lupus Erythematosus: A Bioinformation-Based Analysis.J Inflamm Res. 2024 Jan 27;17:507-526. doi: 10.2147/JIR.S439779. eCollection 2024. J Inflamm Res. 2024. PMID: 38298525 Free PMC article.
References
-
- Vafadari B, Salamian A, Kaczmarek L. MMP-9 in translation: from molecule to brain physiology, pathology, and therapy. J Neurochem. 2016;139(Suppl 2):91–114. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
